RVL Pharmaceuticals plc Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
Cash Flows from Operating Activities:
Net loss from continuing operations
Net income from discontinued operations
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Share compensation
Impairment of intangibles and fixed assets
Reclassification adjustment of cumulative foreign currency translation losses to earnings
Change in fair value of debt
Change in fair value of warrants
Impairment of intangible assets
Impairment of goodwill
Deferred income tax benefit
Deferred income tax expense (benefit)
(Gain) loss on sale of fixed and leased assets
Gain on sales of product rights, net
Gain on sales of discontinued operations
Bad debt provision
Non-cash interest expense and amortization of deferred financing and loan origination fees
Amortization of deferred financing and loan origination fees
Write off of deferred financing and loan origination fees
Financing fees recognized in earnings associated with debt

Change in operating assets and liabilities:
Accounts receivable and other receivables
Inventories, net
Prepaid expenses and other current and non-current assets
Trade accounts payable
Accrued and other current liabilities
Net cash used in operating activities
Cash Flows from Investing Activities:
Proceeds from discontinued operations
Proceeds from sale of fixed and leased assets
Payments on disposal of leased assets
Purchases of property, plant and equipment
Net cash provided by investing activities
Cash Flows from Financing Activities:
Payments to affiliates
Payments on finance lease obligations, ASC840
Payments on finance lease obligations
Proceeds from insurance financing loan
Payments on insurance financing loan
Payments for taxes related to net share settlement of share-based awards
Repayment of insurance financing loan
Proceeds from issuance of debt, net of issuance costs
Proceeds from purchases of stock under ESPP
Proceeds from issuance of ordinary shares under ESPP
Debt repayments
Repurchases of ordinary shares
Net cash provided by (used in) financing activities

Net change in cash and cash equivalents
Effect on cash of changes in exchange rate
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Cash paid for interest
Cash paid for taxes
Purchase of fixed assets by entering into capital lease

Comments